NIH-funded research R01 grant

Morning light to improve heart and blood sugar health in adults with Type 1 Diabetes

Official title: Morning light treatment to improve cardiometabolic health in adults with Type 1 Diabetes: A Pilot and Feasibility Trial

Funded at Northwestern University · NIH-11445915 · Data updated 2026-11-12

A small trial tests whether morning bright light can improve blood sugar control and blood pressure in adults with Type 1 Diabetes.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNorthwestern University
NIH-funded
Lab location1 site (Chicago, United States)
Project startAugust 10, 2026
Project endApril 30, 2029
Funding year2026
Award (this year)$320,000
NIH project number1R01DK144169-01A1
Project IDNIH-11445915 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 25–50 with Type 1 Diabetes and an HbA1c between 7.5% and 13% who can use light therapy daily.

Less likely to help

Patients who cannot tolerate bright light or have conditions worsened by light exposure may not benefit.

What this research studies

This project will study 60 adults with Type 1 Diabetes, ages 25–50, who will be randomly assigned to receive morning bright light or a control condition for several weeks. Researchers will track changes in blood sugar using continuous glucose monitoring and monitor blood pressure, aiming to see if this non-drug intervention improves circadian rhythms and metabolic health. The study will also assess how easy the treatment is to use, whether people stick to it, and whether it is acceptable to patients. If the approach shows promise, it could lead to a simple, safe way to support cardiovascular and glycemic health in T1D.

Why it matters

Potential benefit: If successful, patients may experience better blood sugar control and lower blood pressure through a non-pharmacologic, easy-to-use morning light therapy.

How similar studies have gone: Morning light therapy has helped circadian health in other groups, but this is the first test in people with Type 1 Diabetes.

Where this research is happening

  • Northwestern University
    Chicago, United States
    Active

Researchers

  • Principal investigator: Knutson, Kristen — Northwestern University
  • Study coordinator: Knutson, Kristen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.